The expressions of tRFdb-3003a/b was significantly correlated with IDH-mutants status in glioma patients (both P < 0.05), tRFdb-3003a and tRFdb-3003b may tend to raise in the patients with IDH-mutants. This evidence concerns the gene IDH1 and central nervous system cancer.